A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 8,404 shares of IONS stock, worth $305,317. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,404
Previous 7,624 10.23%
Holding current value
$305,317
Previous $363,000 7.44%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $31,246 - $40,450
780 Added 10.23%
8,404 $336,000
Q2 2024

Aug 12, 2024

BUY
$36.45 - $47.7 $9,513 - $12,449
261 Added 3.54%
7,624 $363,000
Q1 2024

May 09, 2024

SELL
$42.03 - $53.55 $41,147 - $52,425
-979 Reduced 11.74%
7,363 $319,000
Q4 2023

Feb 07, 2024

BUY
$43.39 - $51.63 $67,861 - $80,749
1,564 Added 23.07%
8,342 $422,000
Q3 2023

Nov 08, 2023

SELL
$38.5 - $47.13 $14,976 - $18,333
-389 Reduced 5.43%
6,778 $307,000
Q2 2023

Jul 28, 2023

BUY
$34.73 - $43.33 $45,183 - $56,372
1,301 Added 22.18%
7,167 $294,000
Q1 2023

May 10, 2023

SELL
$33.58 - $41.2 $9,838 - $12,071
-293 Reduced 4.76%
5,866 $209,000
Q4 2022

Feb 10, 2023

BUY
$37.12 - $46.52 $35,264 - $44,194
950 Added 18.24%
6,159 $232,000
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $31,935 - $42,528
-874 Reduced 14.37%
5,209 $230,000
Q2 2022

Aug 09, 2022

BUY
$31.71 - $43.0 $15,442 - $20,941
487 Added 8.7%
6,083 $225,000
Q1 2022

May 16, 2022

BUY
$29.88 - $37.04 $167,208 - $207,275
5,596 New
5,596 $207,000
Q4 2021

Feb 23, 2022

SELL
$25.61 - $35.1 $346,861 - $475,394
-13,544 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$33.54 - $40.55 $454,265 - $549,209
13,544 New
13,544 $454,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.